These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4594363)

  • 21. Mechanisms of immunologic enhancement.
    Amos DB; Cohen I; Klein WJ
    Transplant Proc; 1970 Mar; 2(1):68-75. PubMed ID: 4107294
    [No Abstract]   [Full Text] [Related]  

  • 22. Techniques for orthotopic liver transplantation in the rat and some studies of the immunologic responses to fully allogeneic liver grafts.
    Zimmermann FA; Butcher GW; Davies HS; Brons G; Kamada N; Türel O
    Transplant Proc; 1979 Mar; 11(1):571-7. PubMed ID: 377696
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody-dependent lymphocyte-mediated cytotoxicity in an allogeneic human system. II. Evidence for HL-A specificity.
    Dickmeiss E; Nielsen LS
    Scand J Immunol; 1974; 3(2):199-207. PubMed ID: 4822686
    [No Abstract]   [Full Text] [Related]  

  • 24. Passive enhancement of rat renal allografts with only partial cover of the incompatible Ag-B specificities.
    Fabre JW; Morris PJ
    Transplantation; 1974 Nov; 18(5):436-42. PubMed ID: 4610922
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibody-mediated graft rejection across weak histocompatibility barriers.
    Denham S; Hooton J; Mayol R; Barfoot R; Wrathmell AB
    Transplant Proc; 1979 Jun; 11(2):1409. PubMed ID: 382525
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-tumor activity in human serum: antibodies detecting blood-group-A-like antigen on the surface of tumor cells in culture.
    Bloom ET; Fahey JL; Peterson IA; Geering G; Bernhard M; Trempe G
    Int J Cancer; 1973 Jul; 12(1):21-31. PubMed ID: 4790705
    [No Abstract]   [Full Text] [Related]  

  • 27. Escape from sensitization to HL-A antibodies.
    Miyajima T; Hirata AA; Terasaki PI
    Tissue Antigens; 1972; 2(1):64-73. PubMed ID: 4116684
    [No Abstract]   [Full Text] [Related]  

  • 28. Humoral factors in specific unresponsiveness to transplantation antigens.
    Brent L; Kilshaw PJ
    Transplant Proc; 1976 Jun; 8(2):209-15. PubMed ID: 779181
    [No Abstract]   [Full Text] [Related]  

  • 29. Induction of immunologic enhancement in rats by use of antigen-antibody complexes.
    Marquet RL; Heystek GA; van Leersum RH
    Transplant Proc; 1977 Mar; 9(1):949-51. PubMed ID: 325826
    [No Abstract]   [Full Text] [Related]  

  • 30. Abrogation of cell-mediated immunity by hyperimmune alloantiserum: mechanisms and correlation with allograft enhancement.
    Cohen JM; Yang SS; Law LW
    Int J Cancer; 1974 Apr; 13(4):463-77. PubMed ID: 4135340
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibody turnover by enhanced rat kidneys.
    French ME
    Transplant Proc; 1973 Mar; 5(1):621-3. PubMed ID: 4572122
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro model of hyperacute organ rejection by allotransplantation sera.
    Wartenberg J; Milgrom F
    Transplant Proc; 1979 Jun; 11(2):1407-8. PubMed ID: 382524
    [No Abstract]   [Full Text] [Related]  

  • 33. Heterologous antisera for human histocompatibility testing.
    Balner H; Gabb BW; Dersjant H; Van Vreeswijk W; Van Leeuwen A; Van Rood JJ
    Transplant Proc; 1971 Jun; 3(2):1088-98. PubMed ID: 4944049
    [No Abstract]   [Full Text] [Related]  

  • 34. Specificity of antileukemia sera prepared by immunization with leukemia cells admixed with normal antigen-blocking sera.
    Smith PJ; Robinson CM; Reif AE
    Cancer Res; 1974 Jan; 34(1):169-75. PubMed ID: 4129197
    [No Abstract]   [Full Text] [Related]  

  • 35. The early effects of alloantibody and complement on rat kidney allografts.
    French ME
    Transplantation; 1972 May; 13(5):447-51. PubMed ID: 4557794
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies of the antibodies against HLA, Ia-like, Fc, and/or C3 receptors present in pretransplant sera: anti-B-cell antibodies not associated with accelerated graft loss.
    Soulillou JP; Peyrat MA; Guenel J
    Transplant Proc; 1978 Jun; 10(2):475-7. PubMed ID: 354139
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunologic enhancement induced by antibody fragments.
    Cruse JM; Forbes JT; Gillespie GY; Lewis GK
    Z Immunitatsforsch Allerg Klin Immunol; 1970; 140(3):259-67. PubMed ID: 4251393
    [No Abstract]   [Full Text] [Related]  

  • 38. Automated red cell antibody analysis. A parallel study. II. Identification of serological specificity.
    Perrault R; Högman C
    Vox Sang; 1971 Apr; 20(4):356-70. PubMed ID: 4999319
    [No Abstract]   [Full Text] [Related]  

  • 39. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
    Kieler J
    Ser Haematol; 1972; 5(4):93-122. PubMed ID: 4133765
    [No Abstract]   [Full Text] [Related]  

  • 40. Specificity of heterologous antisera to components solubilized from rat thymocyte membranes.
    Eshhar Z
    Eur J Immunol; 1973 Nov; 3(11):668-73. PubMed ID: 4589167
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.